pentavalent vaccine.pptx
TRANSCRIPT
-
7/30/2019 PENTAVALENT VACCINE.pptx
1/18
-
7/30/2019 PENTAVALENT VACCINE.pptx
2/18
The pentavalent vaccine which wasintroduced in Nepal from April 2009 is acombination of five vaccines in one againstthe diseases: diphtheria, tetanus, whooping
cough, hepatitis B and Haemophilus influenzatype b (the bacteria that causes meningitis,pneumonia and otitis).
It has also led to a reduction in cases ofimmuno-preventive illnesses, especiallymeningitis caused by Haemophilus influenzatype b.
-
7/30/2019 PENTAVALENT VACCINE.pptx
3/18
The National Immunization Programme (at the
time known as the Expanded Programme on
Immunization - EPI) was initiated in 1979 in
three districts with only two antigens (BCG and
DPT) and was rapidly expanded to include all 75
districts with all six recommended antigens
(BCG, DTP, OPV, and measles) by 1988.
In 2003, with the support of the GAVI
Alliance, monovalent Hepatitis B (HepB)
vaccine was introduced, which was lateradministered as a single tetravalent (DPT-HepB)
injection.
-
7/30/2019 PENTAVALENT VACCINE.pptx
4/18
In2009,vaccinationagainst Haemophilus influen
zae type b was introduced through out the
nation in a phase wise manner starting in FarWestern (FWDR) and Western (WDR)
Development Regions.
Also in 2009, Japanese encephalitis (JE)vaccine was introduced into the routine
immunizationprogramme in 16 JE endemic
districts following JE mass vaccination
campaigns
-
7/30/2019 PENTAVALENT VACCINE.pptx
5/18
Pentavalent is a conjugate adsorbed vaccine
containing five antigens Diphtheria , Pertussis
, Tetanus , Hepatitis B and Hib (Haemophilus
influenzae type b).
It is a homogenous liquid containing
purified diphtheria and tetanus toxoids,inactivated whooping cough (pertussis)
organisms, highly purified, non-infectious
particles of Hepatitis B surface antigen (HBsAg)
and Hib component as a bacterial subunitvaccine containing highly purified, non-
infectious Haemophilus Influenza type b (Hib)
capsular polysaccharide chemically conjugated
to a protein (Tetanus Toxoid)
-
7/30/2019 PENTAVALENT VACCINE.pptx
6/18
It shouldnot be frozen. It should be stored in
a refrigerator between 4 to 8 degree celsius.
The vaccine should be used before the date
of expiry indicated on vial.When issued to a subcentre,the vaccine
should be used within a week.
The vaccine will lose potency if kept at room
temperature over a longer period of time.
-
7/30/2019 PENTAVALENT VACCINE.pptx
7/18
Pentavalent can be used in future immunizationsession for up to a maximum of 4 weeks, provided thatall of the following conditions are met-
1. The expiry date has not passed.2. The vaccines are stored under appropriate cold chainconditions.3. The vaccine vial septum has not been submerged inwater.4. Aseptic technique has been used to withdraw all doses5. The vaccine vial monitor (VVM), if attached, has notreached the discard point (see figure).
The vaccine should be visually inspected for any foreignparticulate matter and/or variation of physical aspectprior to administration. In event of either being observeddiscard the vaccine.
-
7/30/2019 PENTAVALENT VACCINE.pptx
8/18
Vaccine vial monitors (VVMs) are part of the
label.
The color dot which appears on the label of
the vial is a VVM. This is a time temperature sensitive dot that
provides an indication of the cumulative heat
to which the vial has been exposed.
It warns the end user when the exposure toheat is likely to have degraded the vaccine
beyond an acceptable level.
-
7/30/2019 PENTAVALENT VACCINE.pptx
9/18
The interpretation of the VVM issimple.
Focus on the central square. Itscolour will change progressively.
As long as the color of this square islighter than the colour of the ring,then the vaccine can be used.
As soon as the colour of the central
square is the same colour as the ringor of a darker colour than the ring,then the vial should be discarded.
-
7/30/2019 PENTAVALENT VACCINE.pptx
10/18
-
7/30/2019 PENTAVALENT VACCINE.pptx
11/18
For active immunization of infants and pre-
school children, it is recommended that
three deep intra muscular injection of 0.5 ml
be administered with an interval of fourweeks between doses. (i.e.6,10,14 weeks)
One of the priciple recommendation of
1984,Global Advisory Group is that for childunder one year of age it should be
administered in lateral aspect of thigh.
-
7/30/2019 PENTAVALENT VACCINE.pptx
12/18
A booster dose of Diphtheria, Tetanus,
Pertussis, Hepatitis B and Haemophilus
Influenza type b Conjugate Vaccine Adsorbed
can be given at the age of 15-18 months.
-
7/30/2019 PENTAVALENT VACCINE.pptx
13/18
Fever and mild local rxns are common.
It is estimated that 2 to 6 % of vacinees develop
fever of 39 degree celcius or higher.
5 to 10% experience swelling and induration or
pain lasting more than 48 hrs.Most severe complications are neurological
(encephalitis/encephalopathy, prolonged
convulsions , infantile spasms and Reye
syndrome) The type and rate of severe adverse reactions do
not differ significantly from the DTP, HepB and
Hib vaccine reactions described separately.
-
7/30/2019 PENTAVALENT VACCINE.pptx
14/18
Individuals infected with the human immune-
deficiency virus (HIV), both asymptomatic
and symptomatic, should be immunized with
combined vaccine according to standard
schedules.
-
7/30/2019 PENTAVALENT VACCINE.pptx
15/18
Any children who are seriously ill or need
hospitalization.
It should not be repeated if a severe rxn
occur after a previous dose.(such rxnsinclude collapse or shock like
state,persistent screaming
episodes,temperatur above 40 degree C,
convulsions ,other neurological symptomsand anaphylactic reactions)
-
7/30/2019 PENTAVALENT VACCINE.pptx
16/18
Known hypersensitivity to any component of
the vaccine, or a severe reaction to the
previous dose of the combination vaccine or
any of its constituents is an absolute
contraindication to subsequent doses of the
combination vaccine or the specific vaccine
knows to have provoked an adverse reaction.
In this case the vaccine should not be givenas a combination vaccine but DT should be
given instead of DPT and Hep B and Hib
vaccines given separately.
-
7/30/2019 PENTAVALENT VACCINE.pptx
17/18
ADRENALINE INJECTION (1:1000) MUST BEIMMEDIATELY AVAILABLE SHOULD AN ACUTEANAPHYLACTIC REACTION OCCUR DUE TO ANYCOMPONENT OF THE VACCINE.
For treatment of severe anaphylaxis the initialdose of adrenaline is 0.1
0.5mg (0.1
0.5 ml of
1:1000 injection) given s/c or I/m. single doseshould not exceed 1mg (1 ml)
For infants and children the recommended doseof adrenaline is 0.01 mg/kg (0.01ml/kg of 1:1000
injection). Single pediatric dose should notexceed 0.5 mg (0.5ml). The mainstay in thetreatment of severe anaphylaxis is the promptuse of adrenaline, which can be life saving.
-
7/30/2019 PENTAVALENT VACCINE.pptx
18/18